An Open-Label Study to Explore the Clinical Efficacy of GS 7977 With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant
This study is ongoing, but not recruiting participants.
Study NCT01559844
Information provided by Gilead Sciences
First Received on March 5, 2012.
Last Updated on May 22, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
